JNJ-70218902

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-70218902, covering 2026-02-17 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of JNJ-70218902 in Participants With Advanced Stage Solid Tumors [Phase 1]